RE: Uncertain Times For TLY24 Mar 2021 22:22
TLY operate a diversified business model which consists of 3 divisions:
The proposals are to integrate the services and TLY already operate that business model. The proposals are for England only.
The proposals were expected and are great for TLY. The sooner they are implemented the sooner TLY will benefit.
TLY operates a diversified business across 3 divisions:
1) Urgent Care - NHS 111, Urgent Care Centres/Walk in Centres etc
2) Planned Care - Physio, Dermatology, Referral management etc.
3) Insourcing - Helping to reduce the long waiting lists for ops in all 4 UK Nations and Ireland.
Urgent Care
During pandemic, NHS 111 has been promoted by Govn/NHS as the 1st port of call.
For years, both Tory & Labour govns have wanted to reduce A&E waiting and help the NHS save money. NHS 111 was to support that goal by pushing patients to call NHS 111 instead of clogging up A&E with non-emergency conditions.
Covid has pushed NHS 111 to the forefront of everyone's minds.
Going forward, new contracts will start to roll out again and I think these will be on better terms for NHS 111 providers.
Insourcing
Insourcing. Only setup in Oct 2019, few months before pandemic and was already growing strongly before covid hit. Millions of ops have been postponed due to covid and this backlog will have to be reduced by using insourcing.
Insourcing division operate in all 4 UK nations and Republic of Ireland. The govn proposals are for England only. There are over 4m on the waiting lists in England alone and around 10m across all UK nations. Then there's Republic of Ireland.
Planned Care
Physio, dermatology, referral management.
Covid has highlighted the need for people to stay healthy and look after their well being. Planned care is a crucial part of Out of Hospital care, part of integrated care.
TLY are in the right place, at the right time.
Last 5 years:
period revenue, cash, profit/loss
2015 £0.6m, £0.4m, £0.4m
2016 £4m, £1m, £1.4m
2017 £21.3m, £11.3m, £5.6m
2018 £42m, £10.2m, £0.2m
2019 £78m, £7.5m, £1.1m
2020 £105m, £8.9m, £4m
H1-2021 (Sept 2020)
revenue: £54m(H1-2020 £49m),
Gross profit: £10.2m(£9.8m)
Ebitda £2.3m (£1.3m)
Cash £12.3m (March 2020 £8.9m)
https://polaris.brighterir.com/public/totally/news/rns/story/xl6lo3x
Pays dividends
Mcap: £56m